Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dacarbazine (dtic-dome) (1 trial)
ofatumumab (arzerra) (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)